Katie K. Crean-Tate, Chad Braley, Goutam Dey, Emily Esakov, Caner Saygin, Alexandria Trestan, . . . Ofer Reizes. (2021). Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors. BMC.
Chicago Style (17th ed.) CitationKatie K. Crean-Tate, et al. Pretreatment with LCK Inhibitors Chemosensitizes Cisplatin‐resistant Endometrioid Ovarian Tumors. BMC, 2021.
MLA (9th ed.) CitationKatie K. Crean-Tate, et al. Pretreatment with LCK Inhibitors Chemosensitizes Cisplatin‐resistant Endometrioid Ovarian Tumors. BMC, 2021.
Warning: These citations may not always be 100% accurate.